Welcome to our dedicated page for APNU news (Ticker: APNU), a resource for investors and traders seeking the latest updates and insights on APNU stock.
Apeiron Capital Investment Corp. (APNU) is a special purpose acquisition company (SPAC) formed with the intent to merge, acquire, or reorganize with one or more businesses. The company is helmed by CEO Dr. Joel Shulman and is focused on leveraging its capital to facilitate business combinations that create shareholder value.
Recently, Apeiron Capital announced the termination of its Business Combination Agreement with GIO World Health, Ltd., which was initially entered into on March 8, 2023, and amended on May 10, 2023. This decision came due to the company's inability to complete the initial business combination within the stipulated time frame as per its Amended and Restated Certificate of Incorporation. As a result, the company will liquidate and dissolve effective August 14, 2023.
The liquidation process involves redeeming all outstanding shares of common stock issued to public stockholders during its initial public offering. Shareholders will receive a per-share redemption price based on the funds held in the trust account, minus a small amount reserved for dissolution expenses. The public shares will be canceled, and funds will be disbursed without interest to the holders. No action is necessary for beneficial owners holding shares in 'street name,' as their redemption amount will be automatically processed.
The company's sponsor has agreed to waive its redemption rights concerning its founder shares, ensuring an orderly dissolution process. It's important to note that there will be no redemption rights or liquidating distributions for the company's warrants, which will expire worthless.
This development marks a significant turn for Apeiron Capital, concluding its journey as a blank check company. Investors and stakeholders are advised to monitor official channels for further updates and detailed financial reports. The company's leadership remains committed to transparency and regulatory compliance throughout this period.
GIO World Health Ltd has announced a business combination agreement with Apeiron Capital Investment Corp (APNC) to take GIO public, valuing the company at a pre-money enterprise value of $250 million. Post-closing, current GIO shareholders will maintain 100% equity and approximately 80.83% ownership in the combined entity, which will be named GIO World Health Holdings, Inc. The transaction aims to provide a platform for GIO's stem cell treatments and other products. The deal is anticipated to close in the second half of 2023, pending shareholder approvals and customary conditions.
Apeiron Capital Investment Corp. (NYSE: APN U) announced on December 29, 2021, that starting December 30, holders of its IPO units can separately trade shares of Class A common stock (symbol: APN) and warrants (symbol: APN W). No fractional warrants will be issued upon separation, and the units that remain unseparated will continue trading under the symbol APN U. The Company is a blank check firm aiming for mergers or acquisitions, primarily in the financial technology, media, gaming, and wealth-advisory sectors.
Apeiron Capital Investment Corp. closed its IPO of 17,250,000 units at $10.00 each, including the full exercise of the underwriters' over-allotment option. The units began trading on the NYSE under the ticker symbol 'APNU' on November 9, 2021. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with each whole warrant exercisable at $11.50 per share. The Company aims for business combinations mainly in financial technology, media, gaming, and wealth-advisory sectors.
Apeiron Capital Investment Corp. announced the pricing of its initial public offering (IPO) of 15,000,000 units at $10.00 per unit, set to begin trading on the NYSE under the ticker APN U on November 9, 2021. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with whole warrants exercisable at $11.50 per share. The offering is expected to close on November 12, 2021, pending customary conditions. The company intends to focus on mergers in the FTMG sectors, while Cantor Fitzgerald serves as the offering manager.
FAQ
What is Apeiron Capital Investment Corp. (APNU)?
Why is Apeiron Capital dissolving?
What happens to the public shares during the liquidation?
Do shareholders need to take any action to receive the redemption amount?
What happens to the company's warrants?
Who is the CEO of Apeiron Capital Investment Corp.?
Will the shareholders earn interest on the redemption amount?
What was the purpose of the Business Combination Agreement with GIO World Health, Ltd.?
When was the termination of the Business Combination Agreement effective?
How long will it take for the redemption process to complete?
